Binding of tryptamine analogs at h5-HT1E receptors: A structure-affinity investigation

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 10, 2004, Pages 2545-2552

  Dukat, Malgorzata ^a   Smith, Carol ^b   Herrick Davis, Katharine ^b   Teitler, Milt ^b   Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Ergolines; Serotonin receptors

Indexed keywords

SEROTONIN 1E RECEPTOR; TRYPTAMINE;

ARTICLE; BINDING AFFINITY; CELL LINE; HYDROGEN BOND; PROTEIN INTERACTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

CELL LINE; HUMANS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEROTONIN; TRYPTAMINES;

EID: 2142819957     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.03.026     Document Type: Article

References (29)

1. Hoyer D., Hannon J.P., Martin G.R. Pharmacol. Biochem. Behav. 71:2002;533-554
2. Leonhardt S., Herrick-Davis K., Titeler M. J. Neurochem. 53:1989;465-471
3. Amlaiky N., Ramboz S., Boschert U., Plassat J.-L., Hen R. J. Biol. Chem. 267:1992;19761-19764
4. Lovenberg T.W., Erlander M.G., Baron B.M., Racke M., Slone A.L., Siegel B.W., Craft C.M., Burns J.E., Danielson P.E., Sutcliffe J.G. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2184-2188
5. Zgombick J.M., Schechter L.E., Macchi M., Hartig P.R., Branchek T.A., Weinshank R.L. Mol. Pharmacol. 42:1992;180-185
6. McAllister G., Charlesworth A., Snodin C., Beer M.S., Noble A.J., Middlemiss D.N., Iversen L.L., Whiting P. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5517-5521
7. Levy F.O., Gudermann T., Birnbaumer M., Kaumann A.J., Birnbaumer L. FEBS Lett. 296:1992;201-206
8. Gudermann T., Levy F.O., Birnbaumer M., Birnbaumer L., Kaumann A.J. Mol. Pharmacol. 43:1993;412-418
9. McAllister G., Castro J.L. Olivier B., van Vijngaarden I., Soudijn E. Serotonin Receptors and their Ligands. 1997;141-157 Elsevier, Amsterdam
10. Bai F., Yin T., Johnstone E.M., Su C., Varga G., Little S.P., Nelson D.L. Eur. J. Pharmacol. 484:2004;127-139
11. Parker E.M., Izzarelli D.G., Lewis-Higgins L., Palmer D., Shapiro R.A. J. Neurochem. 67:1996;2096-2103
12. Glennon R.A. J. Med. Chem. 46:2003;2795-2812
13. 2 Compounds 48-50 were previously prepared in our laboratories; 48 was examined as its HBr salt and 49 and 50 were examined as their HCl salts
14. Cramer R.D., Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959-5967
15. Glennon R.A., Martin B., Johnson K., End D. Res. Commun. Chem., Pathol. Pharmacol. 19:1978;161
16. Glennon R.A., Liebowitz S.M., Mack E.C. J. Med. Chem. 21:1978;822
17. Glennon R.A., Gessner P.K. J. Med. Chem. 22:1979;428
18. Glennon R.A., Gessner P.K., Godse D., Kline B. J. Med. Chem. 22:1979;1414
19. Glennon R.A., Schubert E., Jacyno J.M. J. Med. Chem. 23:1980;1222
20. Kline T.B., Benington F., Morin R.D., Beaton J.M., Glennon R.A., Domelsmith L., Houk K.N., Rozeboom M.D. J. Med. Chem. 25:1982;1381
21. Glennon R.A., Jacyno J.M., Salley J. Jr. J. Med. Chem. 25:1982;68
22. Glennon R.A., Naiman N.A., Pierson M.E., Smith J.D., Ismaiel A.M., Titeler M., Lyon R.A. J. Med. Chem. 32:1989;1921
23. Ismaiel A.M., Titeler M., Miller K.J., Smith T.S., Glennon R.A. J. Med. Chem. 33:1990;755
24. Dukat M., Miller K., Teitler M., Glennon R.A. Med. Chem. Res. 1:1991;271
25. Glennon R.A., Hong S.-S., Dukat M., Teitler M., Davis K. J. Med. Chem. 37:1994;2828
26. Glennon R.A., Hong S.-S., Bondarev M., Law H., Dukat M., Rakhit S., Power P., Fan E., Kinneau D., Kamboj R., Teitler M., Herrick-Davis K., Smith C. J. Med. Chem. 39:1996;314
27. Tsai Y., Dukat M., Slassi M., MacLean N., Demchyshyn L., Savage J.E., Roth B.L., Hufesein S., Glennon R.A. Bioorg. Med. Chem. Lett. 10:2000;2295
28. Data J.B., Taylor M.L., Forcione M. J. Pharm. Sci. 63:1974;848
29. Baker R.W., Chothia C., Pauling P. Mol. Pharmacol. 9:1973;23-32